Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin

JAMA ◽  
1971 ◽  
Vol 218 (11) ◽  
pp. 1665-1670 ◽  
Author(s):  
S. Krugman
Nephron ◽  
1976 ◽  
Vol 17 (5) ◽  
pp. 402-406 ◽  
Author(s):  
Bijan Nik-Akhtar ◽  
Manijeh Khakpour ◽  
Firouz Panahi ◽  
Ali M. Hesabi

Infection ◽  
1984 ◽  
Vol 12 (4) ◽  
pp. 251-255 ◽  
Author(s):  
J. D. Kark ◽  
E. Witztum ◽  
H. Mazkin ◽  
E. Nili ◽  
Y. L. Danon

PEDIATRICS ◽  
1982 ◽  
Vol 69 (2) ◽  
pp. 230-232
Author(s):  
Paul A. Offit ◽  
Joseph M. Campos ◽  
Stanley A. Plotkin

Haemophilus influenzae type b isolates resistant to ampicillin have been reported with increasing frequency since 1973.1 The mechanism of resistance is usually via production of a plasmid-mediated β-lactamase.2 We report the second clinical isolate of an ampicillin-resistant strain of H influenzae type b with no detectable β-lactamase activity. CASE REPORT A 20-year-old white woman was admitted to The Children's Hospital of Philadelphia with a three-day history of fever to 39 C, cough, tachypnea, and diarrhea. Past medical history was significant for the following: (1) recurrent upper and lower respiratory tract infections first noted at 5 years of age, (2) a selective deficiency of IgG and IgA documented at 8 years of age necessitating monthly immune serum globulin injections, (3) chronic, interstitial pulmonary fibrosis with resultant obstructive and restrictive lung disease, (4) severe cachexia, (5) a chronic, maculopapular facial rash, and (6) recurrent, bilateral serous otitis media and sinusitis.


Sign in / Sign up

Export Citation Format

Share Document